LEGAL INSIGHT | DRUG MARKETING AUTHORIZATION DOSSIER: A CRITICAL LEGAL FILTER BEFORE MARKET ENTRY

Obtaining a drug marketing authorization is not merely an administrative procedure; it is a critical legal checkpoint before a product can be introduced to the market. In practice, the dossier must demonstrate not only the registration request but also the legal status of the applicant, the origin of the product, and the transparency and consistency of all submitted information.

A standard dossier typically includes application documents, relevant authorization letters, legal documents of the applicant and manufacturer, evidence supporting the product’s eligibility for circulation, as well as product labels, instructions for use, and technical documentation.

For imported drugs, the requirements are generally more stringent, as the applicant must prove that the product has been duly authorized or is legally marketed in the country of origin or a reference market. In certain cases, additional documents such as assessment reports issued by competent regulatory authorities and comparison reports demonstrating consistency between the dossier submitted in Vietnam and that approved in foreign jurisdictions may be required.

It is important to note that even minor inconsistencies or deficiencies in key documents—such as authorization letters, product labels, instructions for use, or legal documents of the manufacturer—may result in requests for amendment, supplementation, or significant delays in the review process.

Therefore, conducting a thorough dossier review from the outset is essential. It not only enhances the likelihood of successful acceptance and evaluation but also helps businesses save time, reduce costs, and mitigate legal risks throughout the process of bringing pharmaceutical products to market.